Biosimilars are a relatively new arrival in the pharmaceutical industry, yet their potential drives acquisitions and apparently people not knowing about them is a major faux pas. In a recent PWC survey on top health industry issues, 67 percent of the respondents did not know what a biosimilar is
From March 2016 the first 3D printed drug approved by the FDA is officially available on the U.S. market. Aprecia Pharmaceuticals’ Spritam medication (active ingredient – Levetiracetam), destined for the treatment of partial onset, myoclonic, and primary generalized tonic-clonic seizures (various
Although healthcare IT seems to hardly catch its breath between one data breach and the other, with ransomware lurking at the horizon, the professionals need to prepare for the emerging healthcare trends that will soon shake the medical system – at least for the estimated changes, since there may
Most people enjoy being the center of attention in various circumstances. In medicine, seemingly the patient is the center of attention each time a consultation takes place, but when considering the personalized medicine approach, the usual practices lose their supreme individual–focused status.
Since the single-payer healthcare system is not only a long-debated issue, but also a presidential campaign discussion topic, with one of the candidates supporting the idea of the US healthcare system restructuring into a single-payer type, it would be useful to shed some light on this concept.
In March 2016 the providers of telehealth medicine from Florida received good news. Florida lawmakers passed a bill that focuses on commercial insurance coverage. The key outcome is that telehealth providers will be able to enhance their offerings, as well as their services’ quality. Delivering
